Skip to main content
. 2019 Nov 6;24(5):1365–1375. doi: 10.1007/s10461-019-02720-4

Table 3.

Sensitivity analyses: the associations between of PrEP initiation and HIV risk-related sexual behaviors within heterosexual serodiscordant couples

Mean number of sex acts with study partner, past month Any condomless sexa with study partner, past month Any sex with non-study partner, past month
MD (95% CI) p PP (95% CI) p PP (95% CI) p
1. Censor participants when the study partner living with HIV has been on ART for 6 mos, n = 941
 PrEP initiation − 1.10 (− 1.46 to − 0.75) < 0.001 − 32% (− 35% to − 29%) < 0.001 − 1% (− 3% to 0%) 0.04
 Time since PrEP initiation
  1-month − 1.20 (− 1.65 to − 0.75) < 0.001 − 34% (− 38% to − 31%) <0.001 − 2% (− 3% to 0%) 0.03
  3-months − 0.65 (− 1.11 to − 0.18) 0.01 − 29% (− 33% to − 25%) < 0.001 − 2% (− 4% to 0%) 0.03
  6-months − 0.96 (−1.50 to − 0.42) 0.001 − 30% (− 35% to − 26%) < 0.001 − 2% (− 4% to 1%) 0.14
  12-months − 1.66 (− 2.22 to − 1.10) < 0.001 − 31% (− 35% to − 26%) < 0.001 1% (− 1% to 3%) 0.55
  >12-months − 1.87 (− 2.60 to − 1.15) < 0.001 − 35% (−41% to − 29%) < 0.001 − 1% (−3% to 2%) 0.66
2. Censor participants not adhering to PrEPb, n = 940
 PrEP initiation − 0.99 (− 1.38 to − 0.60) < 0.001 − 31% (− 34% to − 27%) <0.001 − 1% (− 2% to 0%) 0.22
 Time since PrEP initiation
  1-month − 1.17 (− 1.66 to − 0.68) < 0.001 − 35% (− 39% to − 31%) < 0.001 − 1% (− 3% to 1%) 0.21
  3-months − 0.38 (− 0.91 to 0.15) 0.16 − 30% (− 34% to -25%) < 0.001 − 1% (− 3% to 0%) 0.11
  6-months − 0.46 (− 1.02 to 0.11) 0.11 − 30% (− 35% to − 26%) < 0.001 − 1% (− 2% to 2%) 0.60
  12-months − 1.12 (− 1.64 to − 0.60) < 0.001 − 26% (− 30% to − 21%) < 0.001 − 1% (− 2% to 1%) 0.55
  >12-months − 2.03 (− 2.63 to − 1.44) < 0.001 − 29% (− 34% to − 24%) <0.001 0% (− 2% to 2%) 0.97
3. Limit to participants who knew their partner was living with HIV > 3 mos prior enrollment, n = 231
 PrEP initiation − 0.44 (− 0.96 to 0.08) 0.10 − 6% (− 11% to − 1%) 0.02 0% (− 3% to 2%) 0.94
 Time since PrEP initiation
  1-month − 0.68 (− 1.38 to 0.03) 0.06 − 9% (− 16% to − 2%) 0.008 − 2% (− 5% to 1%) 0.22
  3-months − 0.19 (− 0.90 to 0.53) 0.61 − 6% (− 13% to 1%) 0.12 − 3% (− 7% to 0%) 0.05
  6-months 0.27 (− 0.44 to 0.99) 0.45 − 6% (− 13% to 1%) 0.10 − 2% (− 5% to 2%) 0.30
  12-months − 0.21 (− 0.84 to 0.41) 0.50 − 6% (− 12% to 0%) 0.05 1% (− 2% to 4%) 0.58
  >12-months − 0.78 (− 1.34 to − 0.21) 0.01 − 5% (− 11% to 0%) 0.07 2% (− 1% to 5%) 0.19

Associations measured using individual longitudinal data and linear regression models with fixed effects for individuals, fertility intentions (trying, not trying, pregnant), sex with a non-study partner (study partner outcomes only), treatment for a genital infection, use of hormonal contraception, calendar month, and number of sex acts (any condomless sex outcome only)

MD mean difference, CI confidence interval, P p-value, PP percentage point change

aParticipant reports having condomless sex with study partner at least once in the past month

bParticipants took > 80% of expected doses, measured using electronic medication even monitoring (MEMS) bottle caps